Estefanía
Pérez Lopez
Researcher from 2016
Hospital Universitario de la Princesa
Madrid, EspañaPublications in collaboration with researchers from Hospital Universitario de la Princesa (1)
2017
-
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial
Biology of Blood and Marrow Transplantation, Vol. 23, Núm. 1, pp. 53-59